Basic information
- CAS
82585-92-0- Standard SMILES
CCOC(=O)Nc1cc2c(c(N)n1)N=C(c1ccc(C)cc1)CN2- InChIKey
LOSVFNDAEKTRMV-UHFFFAOYSA-N- Molecular formula
- C17H19N5O2
- Average molar mass
- 325.4 g/mol
- Monoisotopic mass
- 325.15387487
Names & identifiers
- Preferred name
- CI 980
- IUPAC
- ethyl N-[5-amino-3-(4-methylphenyl)-1,2-dihydropyrido[3,4-b]pyrazin-7-yl]carbamate
- English name
- CI 980
- Molecular formula
- C17H19N5O2
- Molecular weight
- 325.36506
Names & synonyms
82585-92-0CI 980SPT97238ADCarbamic acid, (5-amino-1,2-dihydro-3-(4-methylphenyl)pyrido(3,4-b)pyrazin-7-yl)-, ethyl esterDTXSID40231891RefChem:918601DTXCID70154382NSC-341932Ethyl (5-amino-3-(p-tolyl)-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamateethyl (5-amino-1,2-dihydro-3-(4-methylphenyl)pyrido(3,4-b)pyrazin-7-yl)carbamateBRN 5131460UNII-SPT97238AD
Show more names
CHEMBL9619NSC341932NSC 341932Q27289332Ethyl(5-amino-3-(p-tolyl)-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamateCarbamic acid,2-dihydro-3-(4-methylphenyl)pyrido[3,4-b]pyrazin-7-yl]-, ethyl esterethyl [5-amino-3-(4-methylphenyl)-1,2-dihydropyrido[3,4-b]pyrazin-7-yl]carbamate
Database identifiers
- CAS
82585-92-0- PubChem CID
- 100669
- DTXSID
DTXSID40231891- ChEMBL
CHEMBL9619- UNII
- SPT97238AD
Properties
Computed structural properties
- XLogP
- 2.3
- Topological polar surface area
- 102 Ų
- Hydrogen bond donors
- 3
- Hydrogen bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 24
- Formal charge
- 0
- Complexity
- 476
Physicochemical properties
- NCI Dictionary of Cancer Terms
- -980 · CI-980
- FDA UNII
- 97238 AD · SPT97238AD
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
Related reactions
0 records
No reaction records under the current filter.
Compound notes
Loading…